鍏充簬鑳惰川姣嶇粏鑳炵槫<\/b>锛�<\/b>GBM<\/b>锛�<\/b><\/p> \n
鑳惰川姣嶇粏鑳炵槫锛圙BM锛夋槸涓€绉嶄腑鏋㈢缁忕郴缁熸渶甯歌鐨勬伓鎬ц偪鐦わ紝鍗犻鍐呰偪鐦ょ殑35.26%鈥� 60.9%銆傛牴鎹渶鏂扮殑棰呭唴鑲跨槫鍒嗙骇鏍囧噯锛屼笘鐣屽崼鐢熺粍缁囷紙WHO锛夊皢鍏跺垎绫讳负WHO IV绾с€侴BM鍏锋湁楂樺害娴告鼎鎬у拰渚佃鎬э紝鍥犳閫氬父鏃犳硶閫氳繃鎵嬫湳灏嗗叾褰诲簳娓呴櫎锛屼粠鑰屽鑷磋偪鐦ょ殑蹇€熷鍙戙€傚敖绠BM鐨勬不鐤楀湪鎵嬫湳鍒囬櫎銆佹斁鐤楀拰鍖栧娌荤枟绛夐鍩熶竴鐩村湪涓嶆柇鏀硅繘涓庡皾璇曪紝浣嗗叾棰勫悗骞舵湭寰楀埌瀹炶川鎬ф敼鍠勩€備腑浣嶇敓瀛樻椂闂翠粛鐒跺彧鏈�14.6涓湀銆傛牴鎹編鍥界缁忓绉戝尰鐢熷崗浼氱殑缁熻锛屽湪瑗挎柟鍥藉姣忓勾鎮BM鐨勪汉鏁版瘮渚嬩负2-3\/10涓囷紝鍗犳墍鏈夊師鍙戞€ц剳閮ㄨ偪鐦ょ殑52%銆備袱骞寸敓瀛樼巼绾�30%銆備簲骞村悗锛屽瓨娲荤巼涓嬮檷鍒�4-5%銆傛牴鎹瓼rost&Sullivan鐨勭粺璁★紝鍦ㄤ腑鍥紾BM鎮h€呭崰鎵€鏈夎剳閮ㄨ偪鐦ゆ偅鑰呯殑46.6%锛�2020骞磋揪鍒�54,<\/span>700渚嬨€傞殢鐫€浜哄彛鑰侀緞鍖栬繘灞曪紝绌烘皵姹℃煋鍜岀瀛愭斁灏勬毚闇茬殑鍔犻噸锛屼腑鍥界殑鏂板彂鐥呬緥鏁伴噺棰勮鍦�2025骞村皢杈惧埌59,<\/span>800渚嬶紝2030骞村皢杈惧埌64,<\/span>400渚嬨€�<\/p> \n
鍏充簬<\/b>CAN008 <\/b><\/p> \n
CAN008鏄竴绉岰D95-Fc铻嶅悎铔嬬櫧锛屽叾閫氳繃涓嶤D95L鐨勭粨鍚堬紝骞叉壈CD95\/CD95L鐨勪俊鍙蜂紶瀵硷紝浠庤€岄樆鏂瑿D95\/CD95L閫氳矾銆侰AN008鍏锋湁鐙壒鐨勫弻閲嶄綔鐢ㄦ満鍒讹紝涓嶄絾鍙互鎶戝埗鑲跨槫缁嗚優鐨勭敓闀垮拰杩佺Щ锛岃繕鍙互鎶戝埗鐢盋aspase浠嬪鐨凾缁嗚優姝讳骸锛屼慨澶嶅厤鐤姛鑳姐€傛棦寰€涓村簥璇曢獙鏁版嵁琛ㄦ槑锛孋AN008鍏锋湁鑹ソ鐨勫畨鍏ㄦ€э紝鍙互鏈夋晥鎻愰珮GBM鎮h€呯殑鐢熷瓨璐ㄩ噺锛屽苟鍙互澶у箙搴﹀欢闀挎偅鑰呯殑鐢熷瓨鏈熴€傚熀浜庢锛屾娲茶嵂鍝佺鐞嗗眬锛圗MA锛夊皢CAN008绾冲叆浼樺厛鑽墿锛圥RIME锛夎鍒掋€�<\/p> \n
娉細娆ф床鑽搧绠$悊灞€锛圗MA锛変簬2016骞�3鏈�7鏃ュ紑濮嬫寮忔帹鍑衡€滀紭鍏堣嵂鐗╋紙Priority Medicines锛孭RIME锛夆€濊鍒掞紝鏃ㄥ湪鍔犻€熷尰鑽煭缂洪鍩熼噸鐐硅嵂鍝佺殑瀹¤瘎杩涚▼銆�<\/p> \n
鍖楁捣搴锋垚鍒惰嵂鏈夐檺鍏徃绠€浠�<\/b><\/p> \n
鍖楁捣搴锋垚鍒惰嵂鏈夐檺鍏徃鏄竴瀹剁珛瓒充簬涓浗鐨勫叏鐞冪綍瑙佺梾鐢熺墿鍒惰嵂鍏徃锛岃嚧鍔涗簬鍒涙柊鐤楁硶鐨勭爺绌躲€佸紑鍙戝拰鍟嗕笟鍖栥€�<\/p> \n
鍖楁捣搴锋垚鐩墠鎷ユ湁13 涓叿鏈夊法澶у競鍦烘綔鍔涚殑鑽墿璧勪骇缁勬垚鐨勫叏闈㈠拰宸紓鍖栫殑绠$嚎锛岄拡瀵逛竴浜涙渶鏅亶鐨勭綍瑙佺柧鐥呭拰缃曡鑲跨槫閫傚簲鐥囥€傚叾涓寘鎷拡瀵规不鐤椾酣鐗圭患鍚堢棁 (MPS II) 鍜屽叾浠栨憾閰朵綋璐Н鐥� (LSD)銆佽ˉ浣撲粙瀵肩殑鐤剧梾銆佽鍙嬬梾 A銆佷唬璋㈢磰涔卞拰缃曡鐨勮儐姹佹筏绉€ц倽鐥咃紝鍖呮嫭 Alagille 缁煎悎鐥� (ALGS)銆佽繘琛屾€у鏃忔€ц倽鍐呰儐姹佹筏绉棁(PFIC) 鍜岃儐閬撻棴閿侊紙BA)锛屼互鍙婅兌璐ㄦ瘝缁嗚優鐦� (GBM)銆�<\/p> \n
鍖楁捣搴锋垚鎴樼暐鎬х殑灏嗗叏鐞冨悎浣滀笌鍐呴儴鐮旂┒鐩哥粨鍚堬紝浠ュ缓绔嬪鏍峰寲鐨勮嵂鐗╃粍鍚堬紝鍚屾椂鎶曞叆鍒扮綍瑙佺柧鐥呮不鐤楃殑涓嬩竴浠e熀鍥犳不鐤楁妧鏈鍩熶箣涓€傚寳娴峰悍鎴愮殑鍏ㄧ悆鍚堜綔浼欎即鍖呮嫭 Apogenix銆丟C Pharma銆丮irum銆佽嵂鏄庣敓鐗┿€丳rivus銆侀┈钀ㄨ濉炲窞澶у鍖诲闄� (UMass) 鍜� LogicBio绛�<\/p>"]; $("#dvExtra").html(content_array[0]);})();